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Members of the “Mycoplasma mycoides cluster” are important animal pathogens
causing diseases including contagious bovine pleuropneumonia and contagious caprine
pleuropneumonia, which are of utmost importance in Africa or Asia. Even if all existing
vaccines have shortcomings, vaccination of herds is still considered the best way
to fight mycoplasma diseases, especially with the recent and dramatic increase of
antimicrobial resistance observed in many mycoplasma species. A new generation of
vaccines will benefit from a better understanding of the pathogenesis of mycoplasmas,
which is very patchy up to now. In particular, surface-exposed virulence traits are
likely to induce a protective immune response when formulated in a vaccine. The
candidate virulence factor L-α-glycerophosphate oxidase (GlpO), shared by many
mycoplasmas including Mycoplasma pneumoniae, was suggested to be a surface-
exposed enzyme in Mycoplasma mycoides subsp. mycoides responsible for the
production of hydrogen peroxide directly into the host cells. We produced a glpO
isogenic mutant GM12::YCpMmyc1.1-1glpO using in-yeast synthetic genomics tools
including the tandem-repeat endonuclease cleavage (TREC) technique followed by the
back-transplantation of the engineered genome into a mycoplasma recipient cell. GlpO
localization in the mutant and its parental strain was assessed using scanning electron
microscopy (SEM). We obtained conflicting results and this led us to re-evaluate the
localization of GlpO using a combination of in silico and in vitro techniques, such as Triton
X-114 fractionation or tryptic shaving followed by immunoblotting. Our in vitro results
unambiguously support the finding that GlpO is a cytoplasmic protein throughout the
“Mycoplasma mycoides cluster.” Thus, the use of GlpO as a candidate vaccine antigen
is unlikely to induce a protective immune response.
Keywords: “Mycoplasma mycoides cluster,” synthetic genomics, mycoplasma virulence traits,
L-α-glycerophosphate oxidase, Triton X-114, scanning electron microscopy
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INTRODUCTION
The “Mycoplasma mycoides cluster” encompasses five pathogenic
members which cause livestock diseases including contagious
caprine and bovine pleuropneumonia, mastitis, septicemia,
arthritis, and pneumonia in ruminants (Fischer et al., 2012).
With the recent and dramatic increase of antimicrobial resistance
observed in many Mycoplasma species (Gautier-Bouchardon,
2018), vaccination of animals is considered the most cost-
effective method to eradicate mycoplasma diseases (Nicholas
et al., 2009). However, most of the commercial mycoplasma
vaccines were developed using empirical approaches and are
often reported to have limited efficacy, duration of immunity
and side effects (Nicholas et al., 2009). The emergence of
synthetic genomics techniques (Lartigue et al., 2009; Chandran
et al., 2014; Tsarmpopoulos et al., 2016) has provided a
complete and functional genetic platform for the study of
mycoplasmas (Lartigue et al., 2014; Labroussaa et al., 2016). In
addition to the development of tailored and effective vaccines,
these tools allow for the production of isogenic mutants
providing a unique opportunity to improve the understanding
of host–pathogen interactions and physiological pathways in
Mycoplasmas (Schieck et al., 2016).
In the absence of a cell wall, proteins such as lipoproteins
present at the mycoplasma cell surface are likely to directly
interact with host cells during infections (Rottem, 2003).
Currently, little is known about the factors and mechanisms
driving Mycoplasma pathogenicity. The only virulence trait in
Mycoplasma mycoides that has been confirmed in vivo involves
the capsular polysaccharide (Jores et al., 2018), which was shown
in vitro to play a role in membrane integrity and adhesion
to host cells (Schieck et al., 2016). More recently, the activity
of the Mycoplasma Ig binding-Mycoplasma Ig protease (MIB-
MIP) system (Arfi et al., 2016) in host–pathogen interactions
has also been observed in infected animals with severe
septicemia (Jores et al., 2018). Additionally, the characterization
of mycoplasma “surfaceomes” allowed for the identification of
many putative surface-associated or surface-exposed proteins
(Krasteva et al., 2014; Reolon et al., 2014). Among them,
several mycoplasma lipoproteins have been proposed to play
a role in mycoplasma pathogenicity, i.e., adhesion to host
cells or immune evasion (Chambaud et al., 1999; Citti et al.,
2010; Browning et al., 2011; Christodoulides et al., 2018).
Many transporters were also identified at the cell surface
and are seen as an adaptive trait of mycoplasmas associated
with their parasitic lifestyle (Razin et al., 1998). Indeed, the
regressive and convergent evolution that shaped and minimized
their genomes, as previously shown for the “Mycoplasma
mycoides cluster” (Lo et al., 2018), forced mycoplasmas to
scavenge for high-energy compounds and metabolites during
host infection. Among these, glycerol and glycerol-related
products are imported using active transporters, namely the
glycerol facilitator factor GlpF (Pilo et al., 2005; Großhennig
et al., 2013) or the ATP-binding cassette (ABC) transporter
of the Gts family (Vilei and Frey, 2001). The latter one is
composed of four genes, namely gtsA, gtsB, gtsC, and gtsD
(gtsABCD cluster), and was described to encode a highly
efficient transporter in highly virulent strains of Mycoplasma
mycoides subsp. mycoides (Vilei and Frey, 2001). Interestingly,
mycoplasmas were suggested to be able to hijack this glycerol
uptake pathway to enhance their virulence (Blötz and Stülke,
2017). The production of hydrogen peroxide (H2O2) as a by-
product of the glycerol assimilation was associated in vitro
with the induction of cytotoxic effects on epithelial cells
(Pilo et al., 2005; Hames et al., 2009). A glycerol kinase
(GlpK) was shown to phosphorylate the imported glycerol
into glycerol-3-phosphate, which in turn is oxidized into
dihydroxyacetone phosphate (DHAP) and H2O2. The enzyme
responsible for the release of H2O2 was identified as the L-
α-glycerophosphate oxidase (GlpO). It appears to be present
in many mycoplasma species and was always found associated
in a so-called glpFKO cluster in members of the “Mycoplasma
mycoides cluster.” GlpO was suggested to be surface-exposed
in Mmm in order to facilitate the production of H2O2 in
the close vicinity of the host cells during Mmm infections
while limiting toxic effects on the mycoplasma cells (Pilo
et al., 2005). Therefore, GlpO has long been considered as
an antigen of choice to potentially elicit protective immunity.
However, GlpO has also been characterized as a cytosolic
dimeric enzyme in other bacteria (Claiborne, 1986; Parsonage
et al., 1998) and notably, it was reported to be predominately
located in the cytoplasm of Mycoplasma pneumoniae (Hames
et al., 2009). Such inconsistencies question the localization of
GlpO in representative members of the whole “Mycoplasma
mycoides cluster.”
In this study, an isogenic Mycoplasma mycoides subsp. capri
GM12 mutant, deficient for glpO, was generated and analyzed by
scanning electron microscopy (SEM) using its parental strain as
a control. Hydrogen peroxide production was also quantified for
both strains in vitro and compared to other mycoplasma species
including several strains of Mycoplasma feriruminatoris. Lastly,
phase partitioning followed by immunoblotting was performed
for all members of the “Mycoplasma mycoides cluster” and the
results were compared to in silico analyses of GlpO amino
acids (aa) sequences. Collectively, our results clearly demonstrate
that GlpO is a cytoplasmic enzyme across the members of the
“Mycoplasma mycoides cluster.”
MATERIALS AND METHODS
Mycoplasma and Yeast Strains
The mycoplasma strains used in this study are listed in the
Table 1. All strains were cultured in SP5 medium at 37◦C
(Labroussaa et al., 2016). Tetracycline (5 µg/ml) was added to the
medium when needed.
Saccharomyces cerevisiae strain VL6-48N (MATα trp1-11
ura3-11 ade2-101 his3-1200 lys2 met14 cir◦) (Larionov et al.,
1997) containing the 1.08 Mb genome of Mycoplasma mycoides
subsp. capri (Mmc) (Lartigue et al., 2009) was used in this study.
Construction of the isogenic mutant GM12::YCpMmyc1.1-
1glpO was performed using the tandem repeat coupled with
endonuclease cleavage (TREC) approach as previously described
(Noskov et al., 2010). Yeast cells were cultured at 30◦C in either
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TABLE 1 | Mycoplasma species used in this study.
Mycoplasma species Strain Origin Isolated Host Accession
number
References
M. leachii 99/014/06 Australia 1999 Calf FR668087.1 Djordjevic et al., 2001
M. leachii PG50T Australia 1963 Cattle CP002108.1 Wise et al., 2012
M. mycoides subsp. capri D2083/91 Switzerland 1991 Goat Thiaucourt et al., 2000
M. mycoides subsp. capri 95010 France 1995 Goat FQ377874.1 Thiaucourt et al., 2011
M. mycoides subsp. capri D2503/91 Switzerland 1991 Goat This study
M. mycoides subsp. capri D2082/91 Switzerland 1991 Goat This study
M. mycoides subsp. capri GM12 United States 1979 Goat CP001621.1 Lartigue et al., 2009
M. capricolum subsp. capricolum 6443.90 France 1990 Goat Vilei et al., 2006
M. capricolum subsp. capricolum 4146 France 1980 Goat Fischer et al., 2012
M. capricolum subsp. capricolum California kidT; ATCC 27343 United States 1955 Goat CP000123.1 Cordy et al., 1955
M. feriruminatoris G5847T Berlin 1993 Ibex Jores et al., 2013
M. feriruminatoris 8756-C13 United States <1987 Goat Jores et al., 2013
M. feriruminatoris G5813/1+2; 322/93 Berlin 1993 Goat This study
M. feriruminatoris G1650; 27/94 Berlin 1993 Goat This study
M. feriruminatoris G1705; 28/94 Berlin 1993 Goat This study
M. feriruminatoris 14/OD_0492 Switzerland 1994 Goat This study
M. feriruminatoris 14/OD_0535 Switzerland 1994 Goat This study
M. capricolum subsp. capripneumoniae F38T Kenya 1976 Goat LN515398.1 Falquet et al., 2014
M. mycoides subsp. mycoides Afadé Cameroon 1968 Cattle LAEX01 Fischer et al., 2015
M. mycoides subsp. mycoides Gladysdale Australia <1964 Cattle CP002107 Wise et al., 2012
M. mycoides subsp. mycoides B237 Kenya 1987 Cattle LAEW01 Fischer et al., 2015
standard rich medium (YPDA, Clontech) or minimal synthetic
medium (SD, Clontech).
Generation of a Mycoplasma mycoides
subsp. capri Strain
GM12::YCpMmyc1.1-1glpO
Construction of the isogenic mutant GM12::YCpMmyc1.1-
1glpO was accomplished using the TREC approach as
previously described (Noskov et al., 2010). Specifically, the
gene glpO at position 286,008–287,173 in the parental genome of
GM12::YCpMmyc1.1 was deleted. This deletion was confirmed
by PCR and Sanger sequencing of the PCR product. Total
DNA was extracted, and genome integrity was verified by
multiplex PCR and pulsed-field gel electrophoresis (PFGE) as
previously described (Labroussaa et al., 2016). The genome
GM12::YCpMmyc1.1-1glpO was isolated in agarose plugs and
transplanted back into the restriction free M. capricolum subsp.
capricolum (Mcap1RE) recipient cells as described before
(Labroussaa et al., 2016). Resulting transplants were selected
on SP4 (Tully et al., 1977) agar medium supplemented with
5 µg/mL tetracycline. The expected genotype was verified
again using multiplex PCR and PFGE as outlined above. The
GM12::YCpMmyc1.1-1glpO genome was sequence-confirmed
using Illumina next generation sequencing.
Expression and Purification of
Recombinant GlpO
Synthetic genes encoding full-length GlpOGM12, N-terminal
GlpOGM12, and C-terminal GlpOGM12 were codon-optimized
for Escherichia coli expression and inserted into the expression
vector pET28a(+) (Novagen) by GenScript. The full-length gene
encoded all 387 aa (glpOGM12), while the N-terminal GlpO
included the first 193 aa (NT-glpOGM12) and the C-terminal GlpO
the remaining 194 aa (CT-glpOGM12). The plasmids containing
glpOGM12, NT-glpOGM12 or CT-glpOGM12 were transformed into
E. coli BL21(DE3). Recombinant clones were grown in Lysogeny
Broth (LB) containing 40 µg/mL kanamycin at 37◦C with
220 rpm until an optical density (OD, measured at 600 nm)
of 0.6 was reached. Expression of the recombinant His6-tagged
GlpO proteins was induced by the addition of isopropyl-
β-D-thiogalactopyranoside (IPTG) to the medium at a final
concentration of 1 mM and continued shaking at 37◦C for
4 h. The culture was centrifuged at 4,000 × g for 20 min
at room temperature (RT) and the cell pellets were frozen at
−20◦C. Purification of the His6-tagged GlpO proteins were
performed using Ni2+-nitrilotriacetic acid (Ni-NTA) metal-
affinity chromatography matrices (Qiagen) under denaturing
conditions and according to the manufacturer’s guidelines. The
eluted recombinant proteins were then loaded onto ultrafiltration
centrifugal devices containing a polyethersulfone membrane
(Thermo Fisher Scientific) for buffer exchange to phosphate
buffered saline (PBS).
Quantification of H2O2 Production
Hydrogen peroxide production was determined as previously
published (Tsarmpopoulos et al., 2016) using the MQuant
peroxide test (Merck) which has a detection range of 0.5–25 µg
of H2O2 per mL of solution. Mycoplasma strains were grown
in 5 mL cultures. The supernatant was discarded, and the cells
were washed twice with incubation buffer (67.6 mM HEPES,
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140 mM NaCl, 7 mM MgCl2, pH 7.3). The cells were re-
suspended in 1.5 mL incubation buffer, transferred into a fresh
microcentrifuge tube and centrifuged at 8,600 × g at 4◦C for
10 min. The pellet was washed with 1 mL incubation buffer
and finally resuspended in 4 mL of the fresh incubation buffer.
Aliquots of 1 mL were adjusted to an OD550 = 1.0. The cell
suspensions were incubated at 37◦C for 1 h and then glycerol
was added to a final concentration of 100 µM. Corresponding
aliquots without any added carbon source served as controls. The
test strips were dipped into the suspensions for 1 s at the indicated
time points and the results were recorded.
Scanning Electron Microscopy (SEM)
The experiment was performed as previously described (Pilo
et al., 2005) with only a few modifications. Briefly, cells of
the GM12::YCpMmyc1.1-1glpO mutant strain and its parental
strain, grown in SP5 medium to stationary phase, were
centrifuged at 4,000 × g for 15 min at 4◦C, washed twice with
PBS before being re-suspended in 1 mL PBS. The samples were
mixed with 16% methanol-free formaldehyde (Thermo Fisher
Scientific) to a final concentration of 4% (v/v). Forty microliters
of fixed culture was centrifuged on to gold-sputtered and poly-
L-Lysine-coated coverslips using a cytospin centrifuge (Hettich
Universal 320, Tuttlingen, Germany) at 125 × g for 5 min
at RT. Thereafter, 0.1% BSA-c/PBS (Aurion, ANAWA Trading,
Wangen, Switzerland) and 0.05 M glycine were used to block
non-specific binding sites and the free aldehydes. The coverslips
were mounted on metal stubs with conductive adhesive tabs (Ted
Pella, Redding, CA, United States) and sputter-coated by electron
beam evaporation with approximately 8 nm of platinum/carbon
(MED020, BalTec, Balzers, Liechtenstein). Two-step immuno-
labeling was carried out using a rabbit polyclonal anti-GlpO
antibody followed by a 15 nm colloidal gold-conjugated goat
anti-rabbit IgG (British Biocell International, United Kingdom)
as previously described (Pilo et al., 2005). Control experiments
included omission of the primary antibody incubation and use of
an irrelevant rabbit primary antibody targeting the alpha smooth
muscle actin (Abcam).
Triton X-114 Partitioning
The Triton X-114 phase partitioning experiments were developed
based on previously published protocols (Bordier, 1981; Regula
et al., 2000; Krasteva et al., 2014). The Mycoplasma cells were
recovered by centrifugation at 10,000 × g for 10 min at 4◦C
and were subsequently washed twice with TE buffer (10 mM
Tris, 1 mM EDTA, pH 8.0). The pellet was resuspended in
1,800 µL of cold re-suspension buffer (154 mM NaCl, 10 mM
Tris, pH 7.4) supplemented with EDTA-free protease inhibitor
(Merck) followed by the addition of 200 µL ice-cold 10%
Triton X-114 (Sigma-Aldrich). The samples were thoroughly
dissolved by vortexing for 30 min followed by rotation for
60 min at 4◦C. Prior to phase separation, 100 µL of each
sample was retained to serve as the total protein content of
the sample. The samples were centrifuged at 12,000 × g for
5 min at 4◦C and the clear supernatant was transferred to a
fresh cold tube followed by 5 min incubation at 37◦C. Visible
phase separation (a clear viscous lower detergent (TX) phase
sharply delineated from an upper aqueous (AQ) phase) was
achieved by centrifugation at 8,000 × g for 3 min at RT. The
upper AQ phase was transferred into a new tube and washed
using 1/10th the volume of cold 10% Triton X-114, while cold
resuspension buffer was added to a final volume of 2 mL to
condense the lower TX-phase. The samples were incubated on
ice for 5 min, followed by 5 min incubation at 37◦C. Phase
separation was again performed by centrifugation at 8,000 × g
for 3 min at RT. The phase separation was repeated two times
and then the AQ-phase was then stored at −20◦C until further
use. Meanwhile, 1,800 µL cold 100% methanol was added to the
TX-Phase, mixed and stored at −20◦C. After at least 24 h, they
were centrifuged at 12,000× g for 10 min at 4◦C. The pellets were
resuspended in 230 µL of 2 × SDS-Sample Buffer. Experiments
that required culturing of the stated Mmm and M. capricolum
subsp. capripneumoniae (Mccp) strains were conducted in a
biosafety level 3 laboratory.
Immunoblotting
Immunoblotting was performed as previously described (Jores
et al., 2019). Briefly, protein samples were separated by sodium
dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE)
using 12% polyacrylamide gels. The separated proteins were
either directly subjected to Coomassie brilliant blue staining
or transferred to nitrocellulose membranes using the Trans-
Blot SD semi-dry transfer system (Bio-rad) at 18 V in Towbin
transfer buffer (25 mM Tris, 192 mM Glycine and 20% (v/v)
methanol). After membrane blocking using 5% milk powder or
2% bovine serum albumin (BSA), the membranes were probed
with either rabbit anti-GlpO serum (Pilo et al., 2005) diluted
at 1:5,000, rabbit anti-LppQ primary antibody (Bonvin-Klotz
et al., 2008) diluted at 1:2,000 or rabbit anti-beta Galactosidase
polyclonal antibody diluted at 1:5,000 followed by incubation
with a horseradish peroxidase (HRP) labeled donkey anti-rabbit
IgG (H+L) (Thermo Fisher Scientific) diluted at 1:10,000. Probed
protein bands were detected using chemiluminescence (Thermo
Fisher Scientific) and were documented using a Vilber-FusionFX-
Machine (Vilber Lourmat SAS, France).
In silico Analyses
Molligen1 (Barre et al., 2004) and MBGD2 (Uchiyama et al.,
2015) databases were used for the comparative genomics analysis
looking at the presence and organization of the glpFKO and
gtsABCD clusters. All GlpO sequences were identified from
NCBI database using the top BLAST hit per genome, using
an E-value cut-off of 1e-5. They were all retrieved and aligned
using the ClustalW algorithm in MEGA7 (Kumar et al., 2016).
The resulting phylogenetic tree was constructed using the
Neighbor-Joining method. In order to improve the overall clarity
of the Figure 1, only GlpO sequences that were not 100%
identical (at the amino acids level) were used to construct
the phylogenetic tree. Sequence information is provided in
Supplementary Table S1.
1https://services.cbib.u-bordeaux.fr/molligen/
2http://mbgd.genome.ad.jp/
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The search for transmembrane domains in GlpO sequences
was performed using TMHMM23 (Krogh et al., 2001) and
TMpred4 (Hofmann and Stoffel, 1993). The search for signal
peptides was done using SignalP 5.05 (Almagro Armenteros et al.,
2019). In addition, we used PSORTb v3.06 (Yu et al., 2010) for
the prediction of subcellular localization of GlpO sequences as
it enables specific prediction in Mycoplasma species. All GlpO
sequences were processed on PSORTb’s online server using the
advanced gram stain option of negative without outer membrane,
using the long output format. Complete PSORTb data are also
available in the Supplementary Table S1.
RESULTS
The GlpO Gene Is Present in All Species
of the Mycoplasma mycoides Cluster
We first retrieved 200 GlpO amino acids sequences from NCBI
(May 2019). To do so, we acquired 207 mycoplasma genomes
consisting of 14 M. mycoides subsp. mycoides, 27 M. mycoides
subsp. capri, 7 M. capricolum subsp. capripneumoniae,
4 M. capricolum subsp. capricolum, 3 M. leachii, 1 M.
feriruminatoris, 9 M. hyorhinis, 11 M. hyopneumoniae,
24 M. gallisepticum, 2 M. pulmonis, 89 M. pneumoniae, 6
M. genitalium, 2 M. cynos, and 8 M. canis genomes. All accession
numbers are listed in the Supplementary Table S1. We observed
that one of the 8 M. canis genomes and six of the 55 genomes
belonging to members of the “Mycoplasma mycoides cluster”
had no significant alignment to GlpO. This was perhaps
because of inter-strain variation or due to poor quality draft
genomes lacking the GlpO region. Given the cut-off we used
in our analysis, we first observed that all GlpO sequences were
conserved, even considering Mycoplasma species spanning the
whole class of Mollicutes (Figure 1). When present in a given
species, the GlpO sequences were highly conserved (Figure 1).
This statement holds true for all mycoplasma species tested,
including all members of the “Mycoplasma mycoides cluster.”
We then assessed the presence of the genes involved in glycerol
metabolism, namely the glpFKO and the gtsABCD clusters across
the Mollicutes class, which mainly includes obligate parasites
found in a wide spectrum of hosts ranging from plants, insects,
animals, and humans. The results of this comparative genomic
analysis are shown in Figure 2. Our analyses revealed that the
structures for both clusters are not perfectly conserved with one
of the genes being physically separated from the rest in several
species including M. hyopneumoniae strain 232, M. pulmonis
strain UAB CTIP and M. genitalium G37. Furthermore, the
genes included in the two clusters were not consistently present
across the entire Mollicutes class, with at least one gene missing
in several species. For instance, the entire glpFKO cluster is
completely missing in several species of the cluster Hominis (i.e.,
M. hominis and M. synoviae) (H, Figure 2), several Ureaplasma
3http://www.cbs.dtu.dk/services/TMHMM/
4https://embnet.vital-it.ch/software/TMPRED_form.html
5http://www.cbs.dtu.dk/services/SignalP/
6https://www.psort.org/psortb/
strains and in the Acholeplasma/Phytoplasma cluster (AAP,
Figure 2). However, the clusters have been retained throughout
the Spiroplasma group (S, Figure 2) except for Mesoplasma
florum L1 and Spiroplasma citri GII-3, which are completely
lacking the glpFKO cluster, at least in the strains analyzed here.
The same observations were found for the gtsABCD cluster
in which gtsA appear to be missing in several species of the
Hominis and Pneumoniae phylogenetic clusters. Additionally,
the entire gtsABCD cluster was found conserved in species
where the glpO gene was absent, including M. bovis strain
PG45 and M. agalactiae strain PG2 (Figure 2). Strikingly, both
clusters are fully retained in all of the examined members of the
“Mycoplasma mycoides cluster” (Mc, Figure 2) allowing for the
cellular localization of the GlpO enzyme to be comprehensively
assessed across the entire cluster.
Generation of the Mutant
GM12::YCpMmyc1.1-1glpO and
Verification of the Specificity of the
Rabbit Anti-GlpO Polyclonal Antibody
To properly investigate the cellular location of GlpO in the
“Mycoplasma mycoides cluster,” we decided to produce an
isogenic mutant strain, namely GM12::YCpMmyc1.1-1glpO,
derived from GM12::YCpMmyc1.1 using the TREC technique
(see section “Materials and Methods”). In addition to verifications
at the genomic level including PFGE and whole genome
sequencing, we performed further characterizations of our
mutant strain by confirming the absence of GlpO-specific
bands via immunoblotting using an anti-GlpO antibody
(Figure 3C, lane 4).
The anti-GlpO antibody was originally produced by
immunization of rabbits with the GlpO protein from the
M. mycoides subsp. mycoides (Mmm) Afadé strain (Pilo et al.,
2005). We anticipated that this GlpO polyclonal antibody would
be able to detect GlpO from all “Mycoplasma mycoides cluster”
species due to their high degree of GlpO aa sequence similarity
(Liljander et al., 2019). Nevertheless, to verify that the anti-GlpO
antibody shows high specificity for the detection of the GlpO
protein, we produced the following recombinant Mmc proteins
in E. coli: GlpOGM12 (1-387 aa), NT-GlpOGM12 (1-193aa), and
CT-GlpOGM12 (194-387aa) as depicted in Figure 3A. Since
GlpO is reportedly a surface-located protein, we opted to
produce these three recombinant GlpO to avoid any potential
problems during protein purification in E. coli. In fact, there
were no issues in the expression and purification of these three
constructs since all were highly soluble. All three recombinant
proteins (Figures 3B,C, lanes 1–3), along with cell lysates of our
GM12::YCpMmyc-1glpO mutant strain and its parental strain
(Figures 3B,C, lanes 4 and 5), were separated by SDS-PAGE
followed by Coomassie brilliant blue gel staining (Figure 3B)
or immunoblotting using the anti-GlpO antibody (Figure 3C).
Figure 3B shows that the recombinant proteins have high purity
and display their anticipated molecular weight, while the proteins
belonging to the cellular lysates of the Mmc strains appear to be
equally loaded. Figure 3C shows that the GlpO-specific signals
are at the expected sizes for the three recombinant GlpO proteins
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FIGURE 1 | Neighbor-Joining phylogenetic tree of GlpO sequences from 12 Mycoplasma species. Identifiers used are locus tags from respective genomes. Coloring
and labeling was performed in R using the ape package (Paradis and Schliep, 2019).
(lanes 1–3), which was also confirmed by immunoblotting
with anti-his antibody (data not shown). More importantly,
a GlpO-specific signal at 42 kDa was observed from total
protein of the parental strain GM12::YCpMmyc1.1 (Figure 3C,
lane 5), while no signal corresponding to GlpO was obtained
in the total protein of GM12::YCpMmyc1.1-1glpO (Figure 3C,
lane 4). This experiment confirmed the absence of GlpO gene
since no corresponding GlpO protein was detected in the
GM12::YCpMmyc1.1-1glpO lysate and it verified the ability of
the anti-GlpO antibody to recognize GlpO. However, several
additional and likely unspecific faint bands were also detected in
the cell lysate of Mmc.
The GM12::YCpMmyc1.1-1glpO Is Not
Able to Produce H2O2 in vitro in
Comparison to Other Mycoplasma
Species, Including M. feriruminatoris
To further validate the true nature of the GM12::YCpMmyc1.1-
1glpO mutant strain, we also tested its inability to produce H2O2
in vitro, in the presence of glycerol. The GM12::YCpMmyc1.1-
1glpO mutant produced no detectable amount of H2O2 in the
presence of glycerol compared to its parental strain, even up
to 1 h after the addition of glycerol (Figure 4A). Specifically,
we observed that H2O2 production of GM12::YCpMmyc1.1
was comparable to that of the wild-type strain GM12.
A H2O2 concentration above 2 mg/L was quantified 5 min
after the addition of glycerol in both cases and plateaued at
8 mg/L after 20 min of incubation. This high concentration
of H2O2 was already reached 2 min post-glycerol addition
in the cells of Mycoplasma leachii (Figure 4A). These
results were further verified using a qualitative colorimetric
on-the-plate H2O2 assay (Supplementary Materials and
Methods and Supplementary Figure S1) using HRP and
3,3′-diaminobenzidine tetrahydrochloride hydrate (DAB).
H2O2 production is revealed by the colonies adopting a
red-brown color due to the oxidation of DAB. Colonies
of M. leachii, Mmc GM12 strain and GM12::YCpMmyc1.1
were all stained dark brown within 10 min (Supplementary
Figures S1A–C, respectively) while the GM12::YCpMmyc1.1-
1glpO mutant colonies remained white (Supplementary
Figure S1D). Since M. feriruminatoris has all of the necessary
genes required for H2O2 production (Figure 2), we examined
H2O2 levels from seven M. feriruminatoris strains, including
the previously characterized strain G5847T (Table 1), which
was previously reported to not produce H2O2 (Jores et al.,
2013). Interestingly, we found that all seven strains produced
detectable amounts of H2O2, albeit with varying kinetics
(Figure 4B). Collectively, these results genetically and
phenotypically confirmed the proper deletion of glpO in
our GM12::YCpMmyc1.1-1glpO mutant strain.
Scanning Electron Microscopy
Experiments Could Not Pinpoint the
Localization of GlpOGM12
In order to assess the cellular localization of GlpO, we performed
SEM on GM12::YCpMmyc1.1-1glpO and its parental strain
GM12::YCpMmyc1.1 as previously described (Pilo et al., 2005)
(Figure 5). Secondary electron micrographs revealed intact
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FIGURE 2 | Distribution of the glpFKO and gtsABCD clusters for different species spanning the entire class of Mollicutes. The presence of a gene is indicated by an
arrow mimicking the coding sequence orientation and colored in violet (glpF ), dark blue (glpK), light blue (glpO), red (gtsA), orange (gtsB), yellow (gtsC), and green
(gtsD). Main phylogenetic groups are indicated: S, Spiroplasma; Mc, Mycoides cluster; H, Hominis; P, Pneumoniae; and AAP, Acholeplasma/Phytoplasma.
FIGURE 3 | Specificity of the anti-GlpO serum. (A) Schematic representation of the three histidine-tagged GlpO peptides produced in E. coli. (B) Purified
GlpOMmcGM12 N-term (lane 1), GlpOMmcGM12 C-term (lane 2), GlpOMmcGM12 full-length (lane 3) as well as total proteins of GM12::YCpMmyc1.1-1glpO (lane 4) and
GM12::YCpMmyc1.1 (lane 5) were checked by SDS-PAGE and visualized using Coomassie staining. (C) Immunoblot was performed on the same samples
previously described (lanes 1–5) using the anti-GlpO serum.
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FIGURE 4 | In vitro production of hydrogen peroxide. (A) The inability of the GM12::YCpMmyc1.1-1glpO mutant strain to produce H2O2 was compared to its
parental strain GM12::YCpMmyc1.1 as well as to the wt Mmc GM12 and M. leachii PG50. (B) The capacity of Mycoplasma feriruminatoris to produce H2O2 was
assessed using the type strain G5847T as well as six additional field strains detailed in Table 1.
Mycoplasma cells without any particular phenotype associated
with the GlpO deletion (Figures 5A,C). Labeling of the
mycoplasma cell surface was observed when cells from both
strains were incubated with anti-GlpO polyclonal antibody
followed by an anti-rabbit secondary antibody conjugated with
gold particles (Figures 5B,D). However, we observed a similar
labeling pattern in both strains, regardless of the presence or
absence of GlpO, indicating that this labeling is not GlpO-
specific and is probably due to unspecific recognition of other
FIGURE 5 | Scanning electron micrographs showing immunogold labeling of
the parental strain GM12::YCpMmyc1.1 (A,B) as well as the mutant strain
GM12::YCpMmyc1.1-1glpO (C,D) incubated with anti-GlpO serum.
Secondary electron micrographs show the cell surface of the mycoplasmas
(A,C). Back-scattered electron micrographs reveal the presence of the
gold-conjugated secondary antibody (B,D). Scale bar, 500 nm.
surface-located mycoplasma proteins by the polyclonal antibody.
The specificity of the secondary antibody was corroborated by
negative controls, in which the primary antibody was omitted, or
an irrelevant primary antibody was used instead. These controls
showed no labeling of the cells (data not shown). As labeling
occurred irrespective of the strain, the SEM results obtained here
using this specific anti-GlpO antibody are not meaningful with
respect to the localization of GlpO on whole Mycoplasma cells.
In silico Analyses Strongly Support the
Cytoplasmic Localization of GlpO
We performed various in silico analyses using GlpO sequences
from different strains of the “Mycoplasma mycoides cluster” in
order to gain information concerning GlpO localization. To this
end, we first searched for putative transmembrane (TM) domains
or signal peptides on the GlpO sequences using TMHMM2.0
and SignalP 5.0. At first, we did not find any TM domains
in any of the GlpO aa sequences tested, including the GlpO
sequence derived from the Mmm Afadé strain (Supplementary
Figure S2A). However, one N-terminal TM domain was
predicted for the already characterized membrane lipoprotein,
LppQ (Supplementary Figure S2B) and six TM regions for
the membrane-associated glycerol facilitator transporter, GlpF
(Supplementary Figure S2C), thus demonstrating the capacity
of the software to detect such domains in mycoplasma protein
sequences. Interestingly, a putative TM domain was detected
using TMHMM2.0 on the N-terminal part of several GlpO
sequences of Mycoplasma gallisepticum including the one from
the strain Rhigh (Supplementary Figure S2D), Mycoplasma canis
PG14 (Supplementary Figure S2E) and Mycoplasma cynos C142
(Supplementary Figure S2F). However, none of these putative
domains was confirmed as signal peptides whereas the signal
peptide previously identified in LppQ amino acids sequence
was identified with high confidence (data not shown). We also
used different prediction software (i.e., Phobius, Psi-Pred, LipoP)
and all gave similar and consistent predictions. The prediction
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software TMpred, which was previously used to predict 2 TM
regions in the GlpO sequence of Mmm Afadé (Pilo et al., 2005),
is the only software tested that indicated the presence of putative
TM domains in GlpO sequences of the “Mycoplasma mycoides
cluster” even if the scores attributed to each of them were
rather low (Supplementary Figure S3). In order to provide a
more comprehensive overview of GlpO subcellular localization
across the “Mycoplasma mycoides cluster” and other closely
related species, we analyzed all GlpO sequences previously used
(Figure 1 and Supplementary Table S1) using PSORTb v3.0,
as this software allows fine tuning for Mycoplasma species. All
GlpO sequences were predicted to be cytoplasmic proteins except
for the GlpO sequences belonging to M. gallisepticum and M.
hyopneumoniae, for which the predictions were inconclusive
(Table S1). Collectively, these in silico analyses argue in favor of
a cytoplasmic localization for GlpO, at least in the “Mycoplasma
mycoides cluster”.
Triton X-114 Fractionations Reveal That
GlpO Is a Cytoplasmic Protein in All
Species of the “Mycoplasma mycoides
Cluster”
To specifically investigate whether GlpO is membrane-
associated or resides in the cytoplasm, we performed Triton
X-114 fractionations with representative species across the
“Mycoplasma mycoides cluster” (Table 1 and Figure 6).
First, phase separation of integral membrane proteins of the
GM12::YCpMmyc1.1 parental strain followed by probing with
an anti-LppQ antibody resulted in a LppQ-specific signal at
∼53 kDa exclusively in the detergent fraction (TX) as expected
(Figure 6A). The same partitioning was also followed by
probing with an anti-beta Galactosidase polyclonal serum.
This protein, present of the GM12::YCpMmyc1.1 genome, is a
known cytoplasmic protein. As expected, we obtained a signal
at ∼120 kDa specific for the E. coli beta-Galactosidase only in
the aqueous (AQ) soluble fraction (Figure 6B). Altogether, these
results demonstrated the pertinence of our Triton X-114 phase
partitioning experiments. No GlpO-specific signal was obtained
when proteins of each fraction of the GM12::YCpMmyc1.1-
1glpO mutant strain were separated and probed using anti-GlpO
(Figure 6C). The same TX-114 phase partitioning experiments
were then conducted on different species of the “Mycoplasma
mycoides cluster” including five Mmc strains (Figure 6D),
one Mycoplasma capricolum subsp. capripneumoniae strain
(Figure 6E), three Mycoplasma capricolum subsp. capricolum
strains (Figure 6F), two Mycoplasma leachii strains (Figure 6G),
three Mycoplasma mycoides subsp. mycoides strains (Figure 6H)
and two Mycoplasma feriruminatoris strains (Figure 6I). All
immunoblots revealed a consistent GlpO-specific signal at
∼42 kDa exclusively in all the AQ fractions, as well as in the total
fractions. No clear GlpO-specific signal was observed in any of
the insoluble fractions. Additionally, tryptic shaving experiments
were conducted on three strains previously included in the Triton
X-114 experiments, namely M. feriruminatoris G5847T, Mmc
GM12 and GM12::YCpMmyc1.1. We did not find any reduction
in GlpO-specific signals when any of the aforementioned
strains were incubated with trypsin (Supplementary Figure S4).
Thus, our in vitro experiments clearly showed that GlpO is a
cytoplasmic enzyme in all tested species of the “Mycoplasma
mycoides cluster.”
DISCUSSION
In this study, we re-evaluated the cellular localization of
GlpO across the whole “Mycoplasma mycoides cluster” using
a combination of in silico and in vitro approaches. GlpO was
first described as a surface-exposed virulence factor in Mmm
Afadé (Pilo et al., 2005). While synthetic genomics tools can be
FIGURE 6 | Immunoblots performed after Triton X-114 phase partitioning showing the in vitro cytoplasmic localization of GlpO in the “Mycoplasma mycoides
cluster.” Immunoblots were carried out using an anti-LppQ antibody (A), the anti-beta Galactosidase polyclonal serum (B) or the anti-glpO antibody (C–H) on total
proteins of GM12::YCpMmyc1.1 (A,B), GM12::YCpMmyc1.1-1glpO (C), five different strains of M. mycoides subsp. capri (D), two strains of M. feriruminatoris (E),
three strains of M. capricolum subsp. capricolum (F), two strains of M. leachii (G), three strains of M. mycoides subsp. mycoides (H), and one strain of
M. capricolum subsp. capripneumoniae (I).
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applied to several mycoplasma species, Mmm is still refractory
to genome transplantation impairing the use of such tools for
its study (Labroussaa et al., 2016). Therefore, the construction
of an isogenic mutant GM12::YCpMmyc1.1-1glpO was carried
out in the phylogenetically closely related subspecies Mmc. The
GM12::YCpMmyc1.1-1glpO mutant and its parental strain were
used to assess GlpO localization using SEM analysis. The surface
labeling observed for the mutant strain, despite the absence
of the GlpO protein, was the same as the one observed for
its parental strain (Figure 5). This clearly indicates unspecific
binding of the anti-GlpO serum to other surface-exposed Mmc
proteins. This is consistent with the fact that unspecific bands
were observed on all immunoblots carried out using proteins of
the GM12::YCpMmyc1.1-1glpO mutant and its parental strain
(Figures 3, 4). The specificity of the anti-GlpO serum could
not be assessed in any of the SEM negative controls included
in the original study (Pilo et al., 2005), and also repeated
in this study. However, the use of the GM12::YCpMmyc1.1-
1glpO isogenic mutant greatly facilitated the interpretation of
the results. In addition to whole genome sequencing, H2O2
quantification confirmed the deletion of the glpO gene as this
mutant was unable to produce H2O2 as previously reported
(Tsarmpopoulos et al., 2016). Interestingly, all M. feriruminatoris
strains tested including the type strain G5847T as well as six
field strains, were able to produce detectable amounts of H2O2,
in contrast to previous findings using the type strain G5847T
(Jores et al., 2013).
Total protein content of 16 mycoplasma strains belonging
to six different species, and including three Mmm strains were
separated using Triton X-114 phase partitioning followed by
anti-GlpO immunoblotting. GlpO was only detected in the
soluble fraction after phase separation confirming its cytoplasmic
localization. GlpO was reported as a predominantly cytoplasmic
enzyme in M. pneumoniae but a dual localization was suggested
due to a faint GlpO-specific signal observed in the insoluble
fraction (Hames et al., 2009). In our study, a GlpO-specific
signal was only observed in the insoluble fraction when
the sample temperature was not kept in accordance with
the protocol prior to the fractionation. GlpO was previously
shown to be a cytoplasmic protein in other bacteria including
Enterococcus casseliflavus (Claiborne, 1986) and many lactic-acid
bacteria which also use glycerol as a carbon or energy source
(Baureder and Hederstedt, 2013).
The reallocation of GlpO to the cytoplasm for the members
of the “Mycoplasma mycoides cluster” implies that mycoplasmas
need to export the generated H2O2 to minimize self-toxicity.
In the absence of H2O2-degrading enzymes in mycoplasmas,
such as catalase or superoxide dismutase, H2O2 could potentially
diffuse freely outside of the mycoplasma cells even if its diffusion
is known to be limited (Bienert et al., 2007). A peroxiredoxin,
belonging to a family of antioxidant enzymes (EC 1.11.1.15) able
to reduce H2O2, was identified in Mycoplasma hyopneumoniae
(Machado et al., 2009). Orthologs have been identified in other
mycoplasmas, including species of the “Mycoplasma mycoides
cluster” such as Mmc strain GM12 (MMCAP2_0054), Mmc
strain 95010 (MLC_0500), Mmm strain PG1 (MSC_0053), but
no precise function in cell detoxification has been proposed
in these organisms. Alternatively, transporters such as GlpF,
the GtsABC proteins or a yet to be discovered one, could
be used to actively pump H2O2 outside of the cells. It
is reasonable to assume that GlpO is likely to be located
in close vicinity of this putative transporter in order to
facilitate the export of H2O2. Therefore, if H2O2 is injected
in the host cells as previously suggested for Mmm (Pilo
et al., 2005), then perhaps H2O2 production is only activated
only when mycoplasma cells are directly interacting with
the host cells in order to avoid any self-generated H2O2
toxicity. Recently, GlpQ was identified as a trigger enzyme
regulating the level of expression of enzymes involved in
different physiological pathways in M. pneumoniae (Schmidl
et al., 2011). It is possible that such an enzyme might
be able to trigger the H2O2 production upon interaction
with host cells in other mycoplasma species. The role of
increasing concentrations of H2O2 in the close vicinity of
mycoplasma cells is still very speculative. Low levels of hydrogen
peroxide have been shown to function as signaling molecules
inducing epithelial cell death (Waghray et al., 2005) or in vitro
NETs formation (Fuchs et al., 2007) and may also be used
by mycoplasmas to escape the immune system or retrieve
nutrients from its host.
It was previously assumed that virulent mycoplasma strains,
producing higher amounts of H2O2, expressed GlpO at their
surface to limit its toxic effect (Vilei et al., 2000; Hames et al.,
2009). Even if we cannot exclude the possibility that GlpO might
be translocated to the mycoplasma cell surface in vivo, this
possibility is certainly not supported by our in silico and in vitro
results. Indeed, no TM regions were detected in silico in any of the
GlpO aa sequences belonging to members of the “Mycoplasma
mycoides cluster” using TMHMM, which is considered to be the
best performing TM prediction program (Moller et al., 2001).
The only GlpO aa sequences suggested to have a TM region,
even if none were confirmed as signal peptides, belong to three
different mycoplasma species including M. gallisepticum. Despite
showing cytotoxicity in vitro, the production of H2O2 was
reported to be dispensable for the virulence of M. gallisepticum
in the tracheas of its natural host (Szczepanek et al., 2014). This
brings into question the role of H2O2 in the pathogenesis of
other Mycoplasma species. Moreover, the presence of both the
glpFKO and gtsABCD genes were suggested to facilitate a higher
level of glycerol uptake ultimately leading to a higher production
of H2O2 (Vilei and Frey, 2001). However, our in silico data
do not support such a correlation since it is frequent to find
pathogenic mycoplasma species in which at least one of these
two pathways is absent, if not both (Figure 2). As previously
shown in several species of spiroplasmas, independent events
leading to the loss of the genes involved in these clusters are
likely to explain this phenomenon (Chang et al., 2014). To the
best of our knowledge, the role of H2O2 as a virulence factor has
never been confirmed in vivo for any of the species belonging
to the “Mycoplasma mycoides cluster.” A challenge experiment
using a recently described infection model for Mmc GM12 in
goats [31], employing the mutant GM12::YCpMmyc1.1-1glpO
and its parental strain would help to clarify whether GlpO is a
true virulence trait in Mycoplasma mycoides.
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Overall, our results certainly modify the current concept of
H2O2 production in the “Mycoplasma mycoides cluster.” Due
to its novel cytoplasmic localization, as determined by our
in vitro studies, it is very unlikely that GlpO can continue to be
considered as a candidate antigen to induce a protective response
in the host in the future. A previous attempt to raise such a
protection in cattle using a recombinant GlpO from Mmm failed
to do so (Mulongo et al., 2013) and it is likely to be the case
in other species. However, hosts’ antibodies from convalescent
animals that survived an Mmc infection have been shown to
reduce H2O2 production in vitro raising the question about the
role of other proteins involved in the glycerol uptake (Liljander
et al., 2019). The generation of a series of isogenic mutants for all
the proteins involved in this complex pathway should shed light
on the exact role of this pathway in mycoplasmas.
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